Osler Collection

Tuberculosis & Leprosy

Uganda national TB/leprosy manual, pulmonary & miliary TB, HIV–TB co-infection, drug interactions and leprosy treatment.

11 resources

This collection offers guidance on tuberculosis and leprosy management in Uganda, focusing on treatment protocols, co-infection with HIV, and drug interactions. It is intended for healthcare professionals and students involved in TB and leprosy care.

01Guidelines & protocolsUganda National TB and Leprosy Control Programme ManualMinistry of Health UgandaInfectious Diseases· 2017· 177 pagesThe manual provides comprehensive guidance for the management and control of tuberculosis and leprosy in Uganda, covering epidemiology, diagnosis, treatment regimens, drug‑resistant TB, TB/HIV co‑infection, preventive therapy, and program monitoring.Start here — Uganda national TB & leprosy manual
02Guidelines & protocolsTB GuidelinesMinistry of HealthGeneral Medicine· 2026· 1 pagesUganda National Tuberculosis and Leprosy Control Programme. Manual for management and control of tuberculosis and leprosy.Read: PREFACE · p. 1TB guidelines
03Lecture slidesBasics in TuberculosisDr. Alphonse OkweraInfectious Disease· 2014· 23 pagesAn introductory lecture covering the transmission, definition, case classification, and global epidemiology of Mycobacterium tuberculosis complex.Basics in TB
04Lecture slidesCME TB PresentationDr. Nagganda Cissy MPulmonology· 32 pagesA clinical presentation outlining the definition, epidemiology, pathophysiology, clinical features, investigations, and management of pulmonary and extrapulmonary tuberculosis, including drug-resistant strains.CME on pulmonary TB
05Clinical reviewsTUBERCULOSISInternal Medicine· 53 pagesRead: pp. 46–49
06Clinical reviewsMILITARY TUBERCULOSIS: A COMPREHENSIVE REVIEW OF EPIDEMIOLOGY, CLINICAL MANIFESTATIONS, DIAGNOSIS, TREATMENT, AND COMPLICATIONSThe 940 Lanzhou Pulmonary Hospital, Lanzhou, Gansu, People's Republic of China; Hospital of Joint Logistics Support Force of PLA, Lanzhou, Gansu, People's Republic of ChinaPulmonology· 31 pagesThis comprehensive review discusses miliary tuberculosis, a severe form of disseminated tuberculosis, including its epidemiology, clinical manifestations, diagnosis, and treatment options.Read: References · p. 24Miliary TB review
07Lecture slidesHIV and TB Co-infection: Mechanisms and Clinical SignificanceBuyinza Michael, Mbabazi PerepetwaInfectious Diseases· 2013· 33 pagesAn educational overview outlining the mechanisms of interaction, clinical significance, and drug management of HIV and Tuberculosis co-infection, with a focus on epidemiology in resource-limited settings like Uganda.HIV–TB co-infection
08Lecture slidesStandard vs Double-Dose Dolutegravir in HIV-TB Co-TreatmentDr. Mulinzi SolomonInfectious Diseases· 2023· 40 pagesA journal club presentation reviewing a Lancet HIV 2023 study on the challenges and implementation of double-dose dolutegravir (DTG) co-treatment with rifampicin in patients with HIV and tuberculosis co-infection.Dolutegravir–rifampicin interaction
09Clinical reviewsAntimycobacterial drugsMakerere University, College of Health Sciences, Department of Pharmacology and TherapeuticsGeneral Medicine· 61 pagesThis document provides an overview of the chemotherapy drugs used in the treatment of tuberculosis (TB) and leprosy, including their mechanisms of action and treatment regimens.Read: Chemotherapy · pp. 1–8Antimycobacterial drugs
10Guidelines & protocolsTREATMENT OF LEPROSY IN ADULTSNational Hansen's Disease Program, World Health OrganizationInfectious Disease· 2018· 2 pagesThis document outlines the recommended treatment regimens for leprosy in adults, detailing dosages and durations for various classifications of the disease.Leprosy in adults
11Guidelines & protocolsTREATMENT OF DRUG-RESISTANT LEPROSY IN ADULTSWorld Health OrganizationInfectious Disease· 2 pagesThis document outlines the treatment regimens for adults with drug-resistant leprosy, detailing combination therapies for different resistance patterns.Drug-resistant leprosy

Collection updated Sep 2026· Access follows each resource's usual availability.

Resources in this collection